PATENT CLAIM ANALYSIS

Application Number: 15764052
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "402000"]

Abstract:
Azolylacryloyl derivatives with hypoxic properties are provided. The compounds have a generic formula: and are suitable for treating sickle cell disease and hypoxia-underlying diseases, e.g. hemorrhagic and traumatic shock, cardiac arrest and cardiogenic shock, traumatic brain injury, cancer, stroke, myocardial infarction, myocardial ischemia, vaso-occlusive crisis, etc.

Claim (Index 8):
The method of  claim 7 , wherein the hypoxia-associated disease or condition is selected from the group consisting of hemorrhagic shock, traumatic shock, cardiac arrest, cardiogenic shock, traumatic brain injury, cancer, stroke, myocardial infarction, myocardial ischemia, and vaso-occlusive crisis.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.40476
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11078690', '10725935', '13396221', '11346546', '14773472']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7718836794374281
- 35 USC 102 Novelty (BERT): 0.5351211009247087
- Combined Prediction Score: 0.748207421586156
- Mean Citation Score: 269.2503439999999
- Max Citation Score: 324.3442
- Similarity Product: 165.87928501758574

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test